Ovarian Cancer Trial, Recruiting (NCT03010124)

Ovarian Cancer Trial, Recruiting NCT03010124 Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03010124 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been newly diagnosed with ovarian cancer, OR
People who have been previously treated for ovarian cancer, whose cancer has come back, who have a stored tumour sample available from their original surgery, and who agree to have a biopsy of the returned cancer guided by a CT scan, OR
People who have been previously treated for ovarian cancer, whose cancer has come back, who have a stored tumour sample available from their original surgery, and who are already scheduled for surgery related to the returned cancer
People who have signed a form agreeing to take part in the trial
People aged 18 or older
People who are enrolled in a social security or health insurance scheme (this applies to the French healthcare system — confirm with trial site)

Who may not be able to join:

People who do not meet the criteria listed above, or who do not wish to receive cancer treatment as part of the trial
People who have a blood clotting problem that would make having a biopsy unsafe

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 (0)1 42 11 43 89

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03010124

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: +33 (0)1 42 11 43 89

More information: https://clinicaltrials.gov/study/NCT03010124

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been newly diagnosed with ovarian cancer, OR
People who have been previously treated for ovarian cancer, whose cancer has come back, who have a stored tumour sample available from their original surgery, and who agree to have a biopsy of the returned cancer guided by a CT scan, OR
People who have been previously treated for ovarian cancer, whose cancer has come back, who have a stored tumour sample available from their original surgery, and who are already scheduled for surgery related to the returned cancer
People who have signed a form agreeing to take part in the trial
People aged 18 or older
People who are enrolled in a social security or health insurance scheme (this applies to the French healthcare system — confirm with trial site)

Who may not be able to join:

People who do not meet the criteria listed above, or who do not wish to receive cancer treatment as part of the trial
People who have a blood clotting problem that would make having a biopsy unsafe

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Registry

ClinicalTrials.gov

Start date

26 September 2016

Est. completion

1 September 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Progression Free Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov